Finance

Lists
OGN:NYSE
Organon & Co
$ 13.90
+0.04%
(+0.0050) 1D
$ 13.90
-0.02% (-0.0021)
After hours
Closed: 11-р сарын 13, 16:00:03 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OGN...
Open
$ 13.90
High
$ 13.90
Low
$ 13.88
Mkt. cap
3.65 тэрбум
Avg. vol.
2.46 сая
Volume
4.00 сая
Dividend
0.58%
Quarterly dividend
$ 0.02
Ex-dividend date
2026 оны 8-р сарын 14
P/E ratio
18.08
52-wk high
$ 13.90
52-wk low
$ 5.69
EPS
$ 0.77
Beta
1.53
Shares outstanding
262.62 сая
No. of employees
10 мян
Open
$ 13.90
High
$ 13.90
Low
$ 13.88
Mkt. cap
3.65 тэрбум
Avg. vol.
2.46 сая
Volume
4.00 сая
Dividend
0.58%
Quarterly dividend
$ 0.02
Ex-dividend date
2026 оны 8-р сарын 14
P/E ratio
18.08
52-wk high
$ 13.90
52-wk low
$ 5.69
EPS
$ 0.77
Beta
1.53
Shares outstanding
262.62 сая
No. of employees
10 мян
News stories
From web sources and news partners
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 мян
Founded1923
HeadquartersJersey City, Нью Жерси, Америкийн Нэгдсэн Улс
SectorHealth Care
IndustryPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
Navann Ty
Exane BNP Paribas
Hold
Downgraded
$ 14.00
+0.7%
04/28/2026
David Amsellem
Piper Sandler
Hold
Upgraded
$ 14.00
+0.7%
04/28/2026
Umer Raffat
Evercore ISI
Hold
Maintained
-
-
04/10/2026
Terence Flynn
Morgan Stanley
Hold
Maintained
$ 9.00
-35.3%
04/10/2026
Glen Santangelo
Barclays
Sell
Maintained
$ 8.00
-42.4%
02/24/2026
Chris Schott
J.P. Morgan
Sell
Maintained
$ 11.00
-20.9%
02/13/2026
Jason Gerberry
Bank of America Securities
Sell
Maintained
-
-
02/13/2026
Last report
2026 оны 10-р сарын 30
Fiscal period
Q3 2026
$ 0.94 / $ 0.95
-0.68%miss
Revenue / Est. (USD)
1.57 тэрбум / 1.58 тэрбум
-0.06%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
1.51 тэрбум
1.46 тэрбум
1.56 тэрбум
1.57 тэрбум
Cost of goods sold
741.00 сая
670.00 сая
711.00 сая
705.00 сая
Cost of revenue
741.00 сая
670.00 сая
711.00 сая
705.00 сая
Research and development expenses
91.00 сая
93.00 сая
90.00 сая
83.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
431.00 сая
424.00 сая
434.00 сая
421.00 сая
Operating expense
522.00 сая
517.00 сая
524.00 сая
504.00 сая
Total operating expenses
1.26 тэрбум
1.19 тэрбум
1.24 тэрбум
1.21 тэрбум
Operating income
244.00 сая
273.00 сая
323.00 сая
365.00 сая
Other non operating income
-18.00 сая
15.00 сая
-3.00 сая
12.00 сая
EBT including unusual items
-148.00 сая
213.00 сая
183.00 сая
255.00 сая
EBT excluding unusual items
103.00 сая
170.00 сая
210.00 сая
265.00 сая
Income tax expense
57.00 сая
67.00 сая
75.00 сая
91.00 сая
Effective tax rate
-38.51%
31.46%
40.98%
35.69%
Other operating expenses
-
-
-
-
Net income
-205.00 сая
146.00 сая
108.00 сая
164.00 сая
Net profit margin
-13.60%
10.00%
6.93%
10.42%
Earnings per share
0.63
0.71
0.85
0.94
Interest and investment income
-
-
-
-
Interest expense
-121.00 сая
-111.00 сая
-108.00 сая
-106.00 сая
Net interest expenses
-121.00 сая
-111.00 сая
-108.00 сая
-106.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
340.00 сая
359.00 сая
403.00 сая
447.00 сая
Gain or loss from assets sale
-
-81.00 сая
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google аппс